Octopus Apollo VCT plc : Issue of Equity and To...
Octopus Apollo VCT plc : Issue of Equity and Total Voting Rights
OCTOPUS APOLLO VCT PLC
15 December 2017
Issue of Equity and Total Voting Rights
Octopus Apollo VCT plc (the "Company") announces the allotment and issue of 1,448,023 Ordinary Shares of 10p each at a price of 49.9p per share to shareholders who elected to receive Ordinary Shares under the Dividend Reinvestment Scheme as an alternative to the interim dividend of 1.6p per share, payable on 15 December 2017.
Application has been made to the London Stock Exchange for admission of the new shares. Admission is expected to become effective on or around 22 December 2017.
The issued share capital and total voting rights of the Company is now 258,362,975 Ordinary 10p Shares.
For further information please contact:
Nicola Board Company Secretary 020 7776 8663
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Octopus Apollo VCT plc via Globenewswire
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.